The following people have accepted invitations to serve on the Editorial Board of JASMS, effective January 1, 2017. Editorial Board Members are invited by the ASMS Board of Directors based on several criteria, including being a frequent contributor and reviewer for the Journal. Duties of Editorial Board members include active support of the Journal’s editorial functions, i.e., reviewing manuscripts, encouraging submissions to JASMS, creative input, and participation in the annual Editorial Board meetings that are held during the ASMS Conference.
Jon Amster (University of Georgia)
Benjamin Bythell (University of Missouri-St. Louis)
Guodong Chen (Bristol-Myers Squibb)
Ivan K. Chu (University of Hong Kong)
Gary L. Glish (University of North Carolina)
Lucinda Hittle (Merck & Co., Inc.)
Rebecca A. Jockusch (University of Toronto)
Lars Konermann (University of Western Ontario)
Barbara S. Larsen (The DuPont Company)
John A. McLean (Vanderbilt University)
Kermit Murray (Louisiana State University)
Rachel Ogorzalek Loo (University of California, Los Angeles)
Ljiljana Pasa-Tolic (Pacific Northwest National Laboratory)
Mary T. Rodgers (Wayne State University)
Brandon Ruotolo (University of Michigan)
Jentaie Shiea (National Sun Yat-Sen University)
Andre Venter (Western Michigan University)
Guido F. Verbeck, IV (University of North Texas)
Dingyi Wen (Biogen Inc.)
Brief biosketches for some of the new Editorial Board members are listed below:
Jon Amster received his B.A. degree in 1977 and his Ph.D. in 1986, both from Cornell University. He was a postdoctoral researcher at the University of California- Irvine from 1987-1988. Jon joined the faculty of the Department of Chemistry at the University of Georgia in 1988, where he is currently Professor and Head of Chemistry. The central theme of his research program is the development of mass spectrometry methods for the structural analysis of biological molecules, with a particular focus on high resolution instrumentation, electron based methods of ion activation, and ion mobility spectrometry.
received an M.Chem. degree from the University of Bath, UK, in 2002 anda Ph.D. from Oregon State University in 2007. He then held Postdoctoral fellowships at the German Cancer Research Center in Heidelberg (2008- 2010) and at the National High Magnetic Field Laboratory (2010-2013). He joined the University of Missouri-St. Louis as an Assistant Professor in 2013. Ben works at the interface between analytical, computational and biophysical chemistry where he strives to understand the structure, reactivity and gas-phase behavior of biologically- and industrially-important chemicals.
Guodong Chen has extensive pharma- ceutical research experience in major pharmaceutical companies, including Eli Lilly, Schering-Plough and Bristol-Myers Squibb. Currently, he heads analytical/ mass spectrometry group at Bristol-Myers Squibb central New Jersey site. Guodong has over 75 research publications in peer- reviewed journals and book chapters, three edited/co-edited books on pharmaceutical and biopharmaceutical analysis, multiple patents on antibody therapeutics and has given over 100 presentations at national/international conferences and academic institutes. He received his Ph.D. in Analytical Chemistry/Mass Spectrometry from Purdue University under the direction of Professor R. Graham Cooks.
Ivan Chu’s group has been innovative in advancing the understanding of radical-mediated protein oxidation. Their pioneering studies of the molecular mechanisms of pathological processes under oxidative stress have extended to biophysical, bioanalytical, and biomedical applications and drug discovery. They have made many inroads implementing and applying new multidimensional liquid chromatography (MDLC)/mass spectrometric hardware for novel research purposes. A faculty member in the Department of Chemistry at the University of Hong Kong since 2002, Ivan is also an editorial board member for the Journal of Mass Spectrometry and Mass Spectrometry Letters. His research into biological mass spectrometry has crystallized over 100 refereed articles.
Lucinda Hittle (formerly Cohen) obtained her B.S. degree in Chemistry from Indiana University, and then received a Ph.D. in Analytical Chemistry from the University of Pittsburgh in 1994 under the direction of Professor David M. Hercules. She then worked with Professor Franz Hillenkamp at the University of Muenster, Germany as an Alexander von Humboldt postdoctoral fellow. She began work in 1996 with Parke-Davis Pharmaceutical Research in the Pharmaceutical Delivery Systems, Analytical Research division in Morris Plains, NJ, and then worked in the Pharmacokinetics, Dynamics & Metabolism department within Parke-Davis, Ann Arbor, MI. from 1999-2007. She joined Merck in 2007 where she is currently Director of the PPDM New Jersey Discovery Bioanalytics Group. Lucinda has served as an adjunct faculty member for Stevens Institute of Technology, Hoboken, NJ. Lucinda served as Treasurer on the ASMS Board of Directors from 2010-2012. She has authored more than 30 research articles and book chapters. Lucinda’s research interests include mass spectrometry, bioanalysis, and sample preparation approaches to increase the quality and speed of high throughput analysis in a drug discovery environment.
Lars Konermann is Professor of Chemistry at The University of Western Ontario in London, ON, Canada. He received his Ph.D. in 1996 from the Max-Planck-Institute in Mulheim, Germany. After completing a post-doctoral fellowship at the University of British Columbia, Lars moved to his current position in 1998. Research in Lars’ laboratory focuses on protein biophysical and bioanalytical chemistry. Many of his projects involve the development and application of new mass spectrometry techniques and computational methods. Lars has been the recipient of the McBryde Medal of the Canadian Society for Chemistry (CSC), the CSC Fred Beamish Award, the Florence Bucke Science Prize, the Ken Standing Award, and the Fred Lossing Award of the Canadian Society for Mass Spectrometry. Lars was recently named Distinguished Research Professor, and he serves as Chair of the Lake Louise Tandem Mass Spectrometry Workshop.
John A. McLean is the Stevenson Professor of Chemistry, Director of the Center for Innovative Technologies, co- Director of the Automated Biosystems Core, and Deputy Director of the Institute for Integrative Biosystems Research and Education at Vanderbilt University. Presently, he serves as the Member-at-Large for Education on the ASMS Board of Directors. John completed his Ph.D. at George Washington University in 2001, then performed postdoctoral research at Forschungszentrum Jülich in Germany, and at Texas A&M University with Prof. David H. Russell in biological mass spectrometry. He joined Vanderbilt University in 2006 as an Assistant Professor of Chemistry through both the Department of Chemistry and the Vanderbilt Institute of Chemical Biology. At Vanderbilt, John and colleagues focus on the conceptualization, design, and construction of structural mass spectrometers, specifically targeting complex samples in systems, synthetic, and chemical biology as well as nanotechnology. His group applies these strategies to forefront translational research areas in drug discovery, personalized medicine, and ‘human-on-chip’ synthetic biology platforms.
Jentaie Shiea received his B.S. in Chemistry in 1981 from National Chung- Hsing University, and M.S. (1988) and Ph.D. (1991) degrees from Montana State University. After post-doctoral training in the Department of Material Science at Penn. State University, he joined National Sun Yat-Sen University as a faculty member in 1991, where he is currently a Distinguished Professor in the Department of Chemistry. In the last decade, Jentaie has devoted himself to promoting mass spectrometric research in Taiwan and throughout Asia. He served as the president of the Taiwan Society for Mass Spectrometry (2009- 2012), and was an executive board member and representative of Region B (Asia and Oceania) of the International Mass Spectrometry Foundation (2009-2016). Jentaie’s research interests have long involved biological and organic mass spectrometry, and his current research interests center around (i) the development of novel ambient ionization techniques for on-site detection of chemical compounds with applications to food safety, antiterrorism, anti-doping, and forensic and environmental chemistry, (ii) interfacing mass spectrometry with TLC, HPLC, and GC, and (iii) applying modern mass spectrometry for clinical diagnoses.
Dingyi Wen earned her B.S. and M.S. de- grees from Zhejiang University, in China, and her Ph.D. in chemistry in 1993 from Boston University, where she focused on protein and peptide chemistry. She has been work- ing in the Research Division at Biogen since 1993. Dingyi is currently a Principal Scien- tist and heads the Analytical Biochemistry group, characterizing protein structures, using mass spectrometry and other modern analyti-cal tools, to support on-going projects in the Research Division.